Sometimes the sides are better than the main dish. That is true with many restaurants, including fast food eateries. However, side dishes often aren't very health. These are some of the fast food side ...

GLP-1s are changing the menu landscape for restaurants as diners fundamentally change how they eat. Here's what you'll start ...

OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif., March 02, 2026--Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. ("Protagonist") (NASDAQ:PTGX) today announced that the U.S. Food and ...

Jollibee Foods Corp. engages in the development, operation, and franchising fast food stores under the trade name Jollibee. It operates through the following segments: Food Service, Franchising, and ...

Nearly 13.8 percent of stroke patients in India are below 45 years, with hypertension identified as the leading risk factor ...

Merck (NYSE:MRK) stock gained 0.4% after the Wall Street Journal reported that the drug giant was splitting its human-health business into two divisions to offset pressures related to the loss of ...

Hyderabad: Nearly two out of every five adults in Hyderabad are living with fatty liver disease — a silent condition now driven largely by lifestyle r.

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

After an FDA rejection of its spinocerebellar ataxia (SCA) therapy, Biohaven was forced to rethink its strategy—cutting R&D spend by 60% and channeling the spirit of a scrappy startup again as it ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Cream cheese + spicy giardiniera + lemon zest. Labneh + minced hot dill pickles + a spoonful of brine. Greek yogurt + salsa macha + lime juice. Once you have something cold and punchy waiting in the ...